These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24165569)

  • 1. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
    Ferracin M; Bassi C; Pedriali M; Pagotto S; D'Abundo L; Zagatti B; Corrà F; Musa G; Callegari E; Lupini L; Volpato S; Querzoli P; Negrini M
    Mol Cancer; 2013 Oct; 12(1):130. PubMed ID: 24165569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
    Shang C; Lu YM; Meng LR
    Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-125b targets ARID3B in breast cancer cells.
    Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
    Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
    Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
    Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
    Wang S; Huang J; Lyu H; Lee CK; Tan J; Wang J; Liu B
    Cell Death Dis; 2013 Mar; 4(3):e556. PubMed ID: 23519125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
    Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
    Scott GK; Goga A; Bhaumik D; Berger CE; Sullivan CS; Benz CC
    J Biol Chem; 2007 Jan; 282(2):1479-86. PubMed ID: 17110380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
    Tang F; Zhang R; He Y; Zou M; Guo L; Xi T
    PLoS One; 2012; 7(5):e35435. PubMed ID: 22693547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
    Xu S; Liu H; Wan L; Zhang W; Wang Q; Zhang S; Shang S; Zhang Y; Pang D
    Cell Death Dis; 2019 Dec; 10(12):920. PubMed ID: 31801944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
    Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
    PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
    PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.
    Trošt N; Hevir N; Rižner TL; Debeljak N
    Int J Mol Med; 2013 Mar; 31(3):717-25. PubMed ID: 23314808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells.
    Hofmann MH; Heinrich J; Radziwill G; Moelling K
    Mol Cancer Res; 2009 Oct; 7(10):1635-44. PubMed ID: 19825990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
    Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
    Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALCAM is indirectly modulated by miR-125b in MCF7 cells.
    Akman HB; Selcuklu SD; Donoghue MT; Akhavantabasi S; Sapmaz A; Spillane C; Yakicier MC; Erson-Bensan AE
    Tumour Biol; 2015 May; 36(5):3511-20. PubMed ID: 25539763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.
    Hannafon BN; Sebastiani P; de las Morenas A; Lu J; Rosenberg CL
    Breast Cancer Res; 2011 Mar; 13(2):R24. PubMed ID: 21375733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.